Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
published in: Lancet Oncology Commission
date of publication: 2017-11-17
main subject: phase III clinical trial, multicenter clinical trial
Cites articles 19
Date
Title
Article - wd:Q48552486